Millennium Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Millennium Management’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-206,254	Closed	-$2.3M	–	7443
2022 Q4	$2.3M	Buy	206,254 +99,703	+94%	+$966K	﹤0.01%	3459
2022 Q3	$599K	Sell	106,551 -28,087	-21%	-$176K	﹤0.01%	4802
2022 Q2	$583K	Buy	+134,638	New	+$765K	﹤0.01%	4829
2022 Q1	–	Sell	-119,783	Closed	-$2.19M	–	7934
2021 Q4	$2.19M	Buy	119,783 +81,611	+214%	+$1.04M	﹤0.01%	3697
2021 Q3	$452K	Buy	38,172 +2,613	+7%	+$38.1K	﹤0.01%	5450
2021 Q2	$611K	Sell	35,559 -23,129	-39%	-$440K	﹤0.01%	5127
2021 Q1	$1.07M	Sell	58,688 -47,580	-45%	-$998K	﹤0.01%	4151
2020 Q4	$2M	Sell	106,268 -56,547	-35%	-$1.22M	﹤0.01%	3238
2020 Q3	$3.44K	Buy	162,815 +35,505	+28%	+$830K	﹤0.01%	2166
2020 Q2	$3.68M	Buy	127,310 +120,898	+1,885%	+$3.64M	0.01%	2047
2020 Q1	$224K	Sell	6,412 -3,705	-37%	-$120K	﹤0.01%	3330
2019 Q4	$247K	Buy	+10,117	New	+$178K	﹤0.01%	3763

Other funds holding OYST

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Millennium Management's OYST Position: Q1 2023 in Review

Millennium Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 206,254 shares — an estimated $2.3M sold.

Millennium Management first reported a position in OYST in Q4 2019 and held it in 12 quarters. The position peaked at $3.68M in Q2 2020. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

Millennium Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Millennium Management sold 206,254 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $2.3M.
Millennium Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
Millennium Management's Oyster Point Pharma, Inc. Common Stock position peaked at $3.68M in Q2 2020.
1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.